Stephanie Lheureux1 article listing Stephanie Lheureux in Nature Communications, indexed by Paperzzz from Crossref and OSF.Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial Nature Communications